Volume 13 Number 11/12 November/December 2012 PDF
1 December 2012. Related: PDFs.
2012
Volume 13 Number 11/12 November/December 2012
1 December 2012. Related: Editorial.
11th International Congress on Drug Therapy in HIV, 11-15 November 2012, Glasgow
1 December 2012. Related: Conference reports.
Issues that divide expert opinion: when to start, HIV and ageing and the impact of HIV on life expectancy
1 December 2012. Related: Conference reports, Ageing and life expectancy.
Dolutegravir: integrase resistance and the impact of the background regimen
1 December 2012. Related: Conference reports, Antiretrovirals.
Updated results on Quad: 96 week data from phase 3 studies
1 December 2012. Related: Conference reports, Antiretrovirals.
HIV/HCV coinfection: early glimpses of an interferon-free future and EuroSIDA incidence data
1 December 2012. Related: Conference reports, Hepatitis coinfection.
Resistance in infants and children receiving ART in South Africa
1 December 2012. Related: Conference reports, Paediatric care.
63rd Annual Meeting of the American Association for the Study of Liver Disease (AASLD), 9-13 November 2012, Boston
1 December 2012. Related: Conference reports.
Cure rates with pipeline HCV drugs: reports from AASLD
1 December 2012. Related: Conference reports, Hepatitis coinfection.
3rd International Workshop on HIV and ageing, 5-6 November 2012, Baltimore
1 December 2012. Related: Conference reports.
BHIVA Autumn Conference, 6-7 October 2012, London
1 December 2012. Related: Conference reports.
Darunavir 800 mg tablet approved in the US
1 December 2012. Related: Antiretrovirals.
FDA approval of generic ARVs
1 December 2012. Related: Treatment access.
d4T – time to move on
1 December 2012. Related: Treatment access.
Global Fund provides ART for 4.2 million people: 2012 update
1 December 2012. Related: Treatment access.
$84 million grant to Zimbabwe to reach universal access in 2012
1 December 2012. Related: Treatment access.
Mark Dybul to be the next executive director of the Global Fund
1 December 2012. Related: Treatment access.
Low incidence of liver-related deaths in HIV positive people without HBV and/or HCV co-infection
1 December 2012. Related: Side effects.
US NIH to enforce open access to clincal trial results
1 December 2012. Related: Treatment access.
Rapid drop in mitochondria in fat biopsies within four weeks of d4T use
1 December 2012. Related: Side effects.
High dose multivitamin use in advanced HIV has no benefit to CD4 and viral load and may cause liver toxicity
1 December 2012. Related: Side effects.
The challenge of adherence during pregnancy and after
1 December 2012. Related: Pregnancy.
ART and adverse birth outcomes in Botswana
1 December 2012. Related: Paediatric care.
UK Standards for HIV Care launched by BHIVA (2012)
1 December 2012. Related: Guidelines.
Quantifying HIV-1 exposure to illuminate resistance to infection
1 December 2012. Related: HIV prevention and transmission.
Immune activation, inflammation and HIV acquisition risk
1 December 2012. Related: HIV prevention and transmission.
Hopes raised by HDAC inhibitor, but uncertainties remain
1 December 2012. Related: Cure-related research, Basic science and immunology.
Post-treatment control of HIV replication and prospects for a functional cure
1 December 2012. Related: Cure-related research, Basic science and immunology.
HIV in the United Kingdom: 2012 report
1 December 2012. Related: Other news.
Hepatitis C in the UK: 2012 report
1 December 2012. Related: Other news.
New Frontiers: Inaugural meeting of the British Society for Nanomedicine
1 December 2012. Related: Other news.
Anti-homosexuality laws back in African parliaments
1 December 2012. Related: Other news.
Bad Pharma: How drug companies mislead doctors and harm patients: by Ben Goldacre
1 December 2012. Related: Book and film reviews.
52nd International Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 9-12 September 2012, San Francisco
1 October 2012. Related: Conference reports.
Study summaries from ICAAC 2012
1 October 2012. Related: Conference reports, Antiretrovirals, Basic science and immunology.
Antiviral activity in vitro with S/GSK1265744
1 October 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Efavirenz interaction studies with TB compounds bedaquiline and delamanid
1 October 2012. Related: Conference reports, Antiretrovirals, PK and drug interactions.
19th IAS World AIDS Conference, 22–25 July 2012, Washington
1 October 2012. Related: Conference reports.
FDA approval of generic ARVs
1 October 2012. Related: Treatment access.
HPTN-052: clinical advantages from earlier treatment
1 October 2012. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Free HIV treatment in the UK for all, irrespective of residency status
1 October 2012. Related: Treatment access.
UK Standards for HIV Care online for comment (2012)
1 October 2012. Related: Guidelines.
Hormonal contraception and the risk of HIV acquisition
1 October 2012. Related: Conference reports, Women's health.
Robin Hood Tax begins in France
1 October 2012. Related: Treatment access.
HIV in England to remain as nationally commissioned specialist service
1 October 2012. Related: Guidelines.
Ritonavir significantly increases exposure to colchicine (gout)
1 October 2012. Related: PK and drug interactions.
Towards an HIV cure: Early developments reported at IAS, part 2
1 October 2012. Related: Conference reports, Cure-related research.
Novartis case enters Indian Supreme court
1 October 2012. Related: Treatment access.
US guidelines include Stribild (Quad) as alternative rather than preferred option for treatment naive adults (2012)
1 October 2012. Related: Guidelines.
Costs for rapid TB test reduced by 40%
1 October 2012. Related: TB coinfection.
Online video interviews between researchers and activists
1 October 2012. Related: Conference reports, Antiretrovirals, Treatment access, HIV prevention and transmission, Cure-related research, Other news.
Ritonavir interaction with quinine is clinically insignificant but may warrant caution
1 October 2012. Related: PK and drug interactions.
FDA approves Quad in US: price may prohibit UK access
1 October 2012. Related: Antiretrovirals.
Discord controllers: characterising a new viremic controller phenotype
1 October 2012. Related: Virology.
AIDS 2012: a non-technical review of the 19th IAS Conference
1 October 2012. Related: Supplements.
Case report: fluticasone, fluconazole and ritonavir interactions
1 October 2012. Related: PK and drug interactions.
IAS USA update adult ARV treatment guidelines (2012)
1 October 2012. Related: Guidelines.
India: Bayer stay order against compulsory licence denied
1 October 2012. Related: Treatment access.
Increased incidence of ischemic stroke amongst HIV positive cohort
1 October 2012. Related: Side effects.
Merck acquires CMX157 and EFdA and starts phase 2 study for new NNRTI
1 October 2012. Related: Antiretrovirals.
Important advances in TB drug development
1 October 2012. Related: TB coinfection.
Volume 13 Number 9/10 September/October 2012
1 October 2012. Related: Editorial.
Jerome Horwitz dies at 93
1 October 2012. Related: In memory, Other news.
Volume 13 Number 9/10 September/October 2012 PDF
1 October 2012. Related: PDFs.